Stay updated on Ublituximab in RMS: Clinical Trial

Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ublituximab in RMS: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new site revision label is shown: v3.5.4 replaces the previous v3.5.3. This indicates a platform update rather than content changes on the page.
    Difference
    0.0%
    Check dated 2026-05-15T15:16:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s UI/display revision has been updated from v3.5.2 to v3.5.3, indicating a minor release change rather than an update to the study record content.
    Difference
    0.0%
    Check dated 2026-04-24T05:53:40.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:45:20.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0. Deleted Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T06:14:02.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added Hartung et al. 'Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis' (Neurol Ther, 2026; online ahead of print). Updated page revision to v3.4.3 (replacing v3.4.2).
    Difference
    0.1%
    Check dated 2026-03-12T03:28:50.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; previous notice about government funding lapse (v3.4.1) removed. These changes affect only site maintenance and operate-status messaging, not trial data, eligibility, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:31:41.000Z thumbnail image

Stay in the know with updates to Ublituximab in RMS: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.